Cytokine levels of the aqueous humour in central serous chorioretinopathy

References

• Gass JD. Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol 1967; 6 (Suppl): 1–139.
   Google Scholar
• Loo RH, Scott IU, Flynn HWJ, Gass JD, Murray TG, Lewis ML, Rosenfeld PJ et al. Factors associated with reduced visual acuity during long‐term follow‐up of patients with idiopathic central serous chorioretinopathy. Retina 2002; 22: 19–24.
   PubMed Web of Science ®Google Scholar
• Prunte C, Flammer J. Circulatory disorders of the choroid in patients with central serious chorioretinopathy. Klin Monbl Augenheilkd 1996; 208: 337–339.
   Google Scholar
• Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Ho A, Orlock D. Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 1994; 112: 1057–1062.
   PubMed Web of Science ®Google Scholar
• Yannuzzi LA, Slakter JS, Gross NE, Spaide RF, Costa DL, Huang SJ, Klancnik JM Jr et al. Indocyanine green angiography‐guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina 2003; 23: 288–298.
   PubMed Web of Science ®Google Scholar
• Chan WM, Lam DS, Lai TY, Tam BS, Liu DT, Chan CK. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 2003; 87: 1453–1458.
   PubMed Web of Science ®Google Scholar
• Wang M, Munch IC, Hasler PW, Prunte C, Larsen M. Central serous chorioretinopathy. Acta Ophthalmol 2008; 86: 126–145.
   PubMed Web of Science ®Google Scholar
• Torres‐soriano ME, Garcia‐aguirre G, Kon‐jara V, Ustariz‐gonzales O, Abraham‐marin M, Ober MD, Quiroz‐mercado H. A pilot study of intravitreal bevacizumab for the treatment of central serous chorioretinopathy (case reports). Graefes Arch Clin Exp Ophthalmol 2008; 246: 1235–1239.
   PubMed Web of Science ®Google Scholar
• Lim JW, Ryu SJ, Shin MC. The effect of intravitreal bevacizumab in patients with acute central serous chorioretinopathy. Korean J Ophthalmol 2010; 24: 155–158.
   PubMedGoogle Scholar
• Funatsu H, Yamashita H, Ikeda T, Mimura T, Eguchi S, Hori S. Vitreous levels of interleukin‐6 and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology 2003; 110: 1690–1696.
   PubMed Web of Science ®Google Scholar
• Koch AE, Polverini PJ, Kunkel SL, Harlow LA, Dipietro LA, Elner VM, Elner SG et al. Interleukin‐8 as a macrophage‐derived mediator of angiogenesis. Science 1992; 258: 1798–1801.
   PubMed Web of Science ®Google Scholar
• Taub DD, Anver M, Oppenheim JJ, Longo DL, Murphy WJ. T lymphocyte recruitment by interleukin‐8 (IL‐8). IL‐8‐induced degranulation of neutrophils releases potent chemoattractants for human T lymphocytes both in vitro and in vivo. J Clin Invest 1996; 97: 1931–1941.
   PubMed Web of Science ®Google Scholar
• Lim JW, Kim MU, Shin MC. Aqueous humor and plasma levels of vascular endothelial growth factor and interleukin‐8 in patients with central serous chorioretinopathy. Retina 2010; 30: 1465–1471.
   PubMed Web of Science ®Google Scholar
• Shin MC, Lim JW. Concentration of cytokines in the aqueous humor of patients with central serous chorioretinopathy. Retina 2011; 31: 1937–1943.
   Web of Science ®Google Scholar
• Gilbert CM, Owens SL, Smith PD, Fine SL. Long‐term follow‐up of central serous chorioretinopathy. Br J Ophthalmol 1984; 68: 815–820.
   PubMed Web of Science ®Google Scholar
• Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, Sone T, Hirayama T et al. Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye (Lond) 2008; 22: 42–48.
   PubMed Web of Science ®Google Scholar
• Bakri SJ, Snyder MR, Reid JM, Pulido JS, Singh RJ. Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology 2007; 114: 855–859.
   PubMed Web of Science ®Google Scholar
• Funk M, Schmidinger G, Maar N, Bolz M, Benesch T, Zlabinger GJ, Schmidt‐erfurth UM. Angiogenic and inflammatory markers in the intraocular fluid of eyes with diabetic macular edema and influence of therapy with bevacizumab. Retina 2010; 30: 1412–1419.
   PubMed Web of Science ®Google Scholar
• Oh IK, Kim SW, Oh J, Lee TS, Huh K. Inflammatory and angiogenic factors in the aqueous humor and the relationship to diabetic retinopathy. Curr Eye Res 2010; 35: 1116–1127.
   PubMed Web of Science ®Google Scholar
• Sohn HJ, Han DH, Kim IT, Oh IK, Kim KH, Lee DY, Nam DH. Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema. Am J Ophthalmol 2011; 152: 686–694.
   PubMed Web of Science ®Google Scholar
• Jonas JB, Tao Y, Neumaier M, Findeisen P. Cytokine concentration in aqueous humour of eyes with exudative age‐related macular degeneration. Acta Ophthalmol 2012; 90: e381–e388.
   PubMed Web of Science ®Google Scholar
• Miao H, Tao Y, Li XX. Inflammatory cytokines in aqueous humor of patients with choroidal neovascularization. Mol Vis 2012; 18: 574–580.
   PubMed Web of Science ®Google Scholar
• Roh MI, Lim SJ, Ahn JM, Lim JB, Kwon OW. Concentration of cytokines in age‐related macular degeneration after consecutive intravitreal bevacizumab injection. Graefes Arch Clin Exp Ophthalmol 2010; 248: 635–640.
   Web of Science ®Google Scholar
• Tong JP, Chan WM, Liu DT, Lai TY, Choy KW, Pang CP, Lam DS. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium‐derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Am J Ophthalmol 2006; 141: 456–462.
   PubMed Web of Science ®Google Scholar
• Noma H, Funatsu H, Mimura T. Vascular endothelial growth factor and interleukin‐6 are correlated with serous retinal detachment in central retinal vein occlusion. Curr Eye Res 2012; 37: 62–67.
   Web of Science ®Google Scholar
• Park SP, Ahn JK. Changes of aqueous vascular endothelial growth factor and interleukin‐6 after intravitreal triamcinolone for branch retinal vein occlusion. Clin Experiment Ophthalmol 2008; 36: 831–835.
   PubMed Web of Science ®Google Scholar
• Boyd SR, Zachary I, Chakravarthy U, Allen GJ, Wisdom GB, Cree IA, Martin JF et al. Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion. Arch Ophthalmol 2002; 120: 1644–1650.
   PubMed Web of Science ®Google Scholar
• Strieter RM, Polverini PJ, Arenberg DA, Walz A, Opdenakker G, Van damme J, Kunkel SL. Role of C‐X‐C chemokines as regulators of angiogenesis in lung cancer. J Leukoc Biol 1995; 57: 752–762.
   PubMed Web of Science ®Google Scholar
• Meleth AD, Agron E, Chan CC, Reed GF, Arora K, Byrnes G, Csaky KG et al. Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci 2005; 46: 4295–4301.
   PubMed Web of Science ®Google Scholar
• Shahar J, Avery RL, Heilweil G, Barak A, Zemel E, Lewis GP, Johnson PT et al. Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin). Retina 2006; 26: 262–269.
   PubMed Web of Science ®Google Scholar
• Hong KH, Ryu J, Han KH. Monocyte chemoattractant protein‐1‐induced angiogenesis is mediated by vascular endothelial growth factor‐A. Blood 2005; 105: 1405–1407.
   PubMed Web of Science ®Google Scholar
• Voskuil M, van Royen N, Hoefer IE, Seidler R, Guth BD, Bode C, Schaper W et al. Modulation of collateral artery growth in a porcine hindlimb ligation model using MCP‐1. Am J Physiol Heart Circ Physiol 2003; 284: H1422–1428.
   Web of Science ®Google Scholar
• Luster AD, Greenberg SM, Leder P. The IP‐10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med 1995; 182: 219–231.
   PubMed Web of Science ®Google Scholar
• Luster AD, Leder P. IP‐10, a ‐C‐X‐C‐ chemokine, elicits a potent thymus‐dependent antitumor response in vivo. J Exp Med 1993; 178: 1057–1065.
   PubMed Web of Science ®Google Scholar
• Elner SG, Strieter R, Bian ZM, Kunkel S, Mokhtarzaden L, Johnson M, Lukacs N et al. Interferon‐induced protein 10 and interleukin 8. C‐X‐C chemokines present in proliferative diabetic retinopathy. Arch Ophthalmol 1998; 116: 1597–1601.
   PubMedGoogle Scholar
• Angiolillo AL, Sgadari C, Taub DD, Liao F, Farber JM, Maheshwari S, Kleinman HK et al. Human interferon‐inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med 1995; 182: 155–162.
   PubMed Web of Science ®Google Scholar